Back
Lexaria Bioscience 10K Form
Sell
26
LEXX
Lexaria Bioscience
Last Price:
2.17
Seasonality Move:
9.56%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2021-04-14 | 10Q | LEXX/Lexaria Bioscience Quarterly |
| 2021-01-14 | 10Q | LEXX/Lexaria Bioscience Quarterly |
| 2020-10-15 | 10K | LEXX/Lexaria Bioscience Annual |
| 2020-06-29 | 10Q | LEXX/Lexaria Bioscience Quarterly |
| 2020-04-03 | 10Q | LEXX/Lexaria Bioscience Quarterly |
| 2020-01-09 | 10Q | LEXX/Lexaria Bioscience Quarterly |
Receive LEXX News And Ratings
See the #1 stock for the next 7 days that we like better than LEXX
LEXX Financial Statistics
Sales & Book Value
| Annual Sales: | $226.21K |
|---|---|
| Cash Flow: | $-1.29M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.64 |
| Price / Book: | 3.26 |
Profitability
| EPS (TTM): | -0.44000 |
|---|---|
| Net Income (TTM): | $-4.85M |
| Gross Margin: | $194.71K |
| Return on Equity: | -93.31% |
| Return on Assets: | -85.62% |
Lexaria Bioscience Earnings Forecast
Key Lexaria Bioscience Financial Ratios
- The Gross Profit Margin over the past 18 years for LEXX is 86.07%.
- The Selling, General & Administrative Expenses for LEXX have been equal to 1,353.61% of Gross Profit Margin.
- The Research & Development expenses have been 1,620.94% of Revenue.
- The Interest Expense is -0.32% of Operating Income.
- The Net Earning history of LEXX is -2,946.33% of Total Revenues.
- Per Share Earnings over the last 19 years have been positive in 10 years.
Lexaria Bioscience Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | LEXX |
| Website: | lexariabioscience.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 58.27 |
| Quick Ratio: | 55.84 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
LEXX Technical Analysis vs Fundamental Analysis
Sell
26
Lexaria Bioscience (LEXX)
is a Sell
Is Lexaria Bioscience a Buy or a Sell?
-
Lexaria Bioscience stock is rated a Sell
The current Lexaria Bioscience [LEXX] share price is $2.20. The Score for LEXX is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.